Cargando…

Cost-Effectiveness of Device-Aided Therapies in Parkinson’s Disease: A Structured Review

BACKGROUND: Despite optimal dopaminergic treatment most patients in moderate to advanced stages of Parkinson’s disease (PD) experience progressively increasing disabilities, necessitating a shift from oral medication to device-aided therapies, including deep brain stimulation (DBS), intrajejunal lev...

Descripción completa

Detalles Bibliográficos
Autores principales:	Smilowska, Katarzyna, van Wamelen, Daniel J., Pietrzykowski, Tomasz, Calvano, Alexander, Rodriguez-Blazquez, Carmen, Martinez-Martin, Pablo, Odin, Per, Chaudhuri, K. Ray
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	IOS Press 2021
Materias:	Systematic Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8150660/ https://www.ncbi.nlm.nih.gov/pubmed/33386813 http://dx.doi.org/10.3233/JPD-202348

Ejemplares similares

Continuous Drug Delivery Aiming Continuous Dopaminergic Stimulation in Parkinson’s Disease
por: van Wamelen, Daniel J., et al.
Publicado: (2018)

Kinds of Harm: Animal Law Language from a Scientific Perspective
por: Pietrzykowski, Tomasz, et al.
Publicado: (2022)

The reality of informed consent: empirical studies on patient comprehension—systematic review
por: Pietrzykowski, Tomasz, et al.
Publicado: (2021)

Comparative Effectiveness of Device-Aided Therapies on Quality of Life and Off-Time in Advanced Parkinson’s Disease: A Systematic Review and Bayesian Network Meta-analysis
por: Antonini, Angelo, et al.
Publicado: (2022)

Blue Light Therapy Glasses in Parkinson's Disease: Patients' Experience
por: Smilowska, Katarzyna, et al.
Publicado: (2019)

Distribution and impact on quality of life of the pain modalities assessed by the King’s Parkinson’s disease pain scale
por: Martinez-Martin, Pablo, et al.
Publicado: (2017)

Close relationships in Parkinson´s disease patients with device‐aided therapy
por: Scharfenort, Monica, et al.
Publicado: (2021)

Why do ‘OFF’ periods still occur during continuous drug delivery in Parkinson’s disease?
por: Rota, Silvia, et al.
Publicado: (2022)

The real-life effect of catechol-O-methyltransferase inhibition on non-motor symptoms in levodopa-treated Parkinson’s disease: opicapone versus entacapone
por: Leta, Valentina, et al.
Publicado: (2023)

Personalised Advanced Therapies in Parkinson’s Disease: The Role of Non-Motor Symptoms Profile
por: Leta, Valentina, et al.
Publicado: (2021)

Covid-19 and Parkinson's disease: Acute clinical implications, long-COVID and post-COVID-19 parkinsonism
por: Leta, Valentina, et al.
Publicado: (2022)

Applications of the European Parkinson’s Disease Association sponsored Parkinson’s Disease Composite Scale (PDCS)
por: Balestrino, Roberta, et al.
Publicado: (2019)

Effects of safinamide on pain in patients with fluctuating Parkinson's disease
por: Grigoriou, Sotirios, et al.
Publicado: (2021)

Nonmotor symptom burden grading as predictor of cognitive impairment in Parkinson’s disease
por: Oikonomou, Panteleimon, et al.
Publicado: (2021)

Drooling in Parkinson’s Disease: Prevalence and Progression from the Non-motor International Longitudinal Study
por: van Wamelen, Daniel J., et al.
Publicado: (2020)

Viruses, parkinsonism and Parkinson’s disease: the past, present and future
por: Leta, Valentina, et al.
Publicado: (2022)

Parkinson's Disease and Post–COVID‐19 Syndrome: The Parkinson's Long‐COVID Spectrum
por: Leta, Valentina, et al.
Publicado: (2021)

Non-oral dopaminergic therapies for Parkinson’s disease: current treatments and the future
por: Ray Chaudhuri, K, et al.
Publicado: (2016)

Identifying Parkinson’s disease subtypes with motor and non-motor symptoms via model-based multi-partition clustering
por: Rodriguez-Sanchez, Fernando, et al.
Publicado: (2021)

Disentangling the PIGD classification for the prediction of cognitive impairment in de novo Parkinson’s disease
por: Urso, Daniele, et al.
Publicado: (2021)

A Proposal for a Comprehensive Grading of Parkinson's Disease Severity Combining Motor and Non-Motor Assessments: Meeting an Unmet Need
por: Ray Chaudhuri, Kallol, et al.
Publicado: (2013)

Correction: A Proposal for a Comprehensive Grading of Parkinson's Disease Severity Combining Motor and Non-Motor Assessments: Meeting an Unmet Need
por: Ray Chaudhuri, Kallol, et al.
Publicado: (2016)

Exploring hyperhidrosis and related thermoregulatory symptoms as a possible clinical identifier for the dysautonomic subtype of Parkinson’s disease
por: van Wamelen, Daniel J., et al.
Publicado: (2019)

Non-motor correlates of wrist-worn wearable sensor use in Parkinson’s disease: an exploratory analysis
por: van Wamelen, Daniel J., et al.
Publicado: (2019)

Modelling the Cost Effectiveness of Treatments for Parkinson’s Disease: An Updated Methodological Review
por: Dams, Judith, et al.
Publicado: (2023)

Safinamide in the treatment pathway of Parkinson’s Disease: a European Delphi Consensus
por: Stocchi, Fabrizio, et al.
Publicado: (2022)

Clinical trajectories and biomarkers for weight variability in early Parkinson’s disease
por: Urso, Daniele, et al.
Publicado: (2022)

Advanced Parkinson’s or “complex phase” Parkinson’s disease? Re-evaluation is needed
por: Titova, Nataliya, et al.
Publicado: (2017)

Cross-sectional analysis of the Parkinson’s disease Non-motor International Longitudinal Study baseline non-motor characteristics, geographical distribution and impact on quality of life
por: van Wamelen, Daniel J., et al.
Publicado: (2021)

The Neuro-Ophthalmological Assessment in Parkinson’s Disease
por: Borm, Carlijn D.J.M., et al.
Publicado: (2019)

Viewpoint and practical recommendations from a movement disorder specialist panel on objective measurement in the clinical management of Parkinson’s disease
por: Odin, Per, et al.
Publicado: (2018)

Validation study of the Parkinson’s Fatigue Scale in advanced Parkinson’s disease
por: Martinez-Martin, Pablo, et al.
Publicado: (2019)

Clinical Characterization of Parkinson's Disease Patients With Cognitive Impairment
por: Simon-Gozalbo, Ana, et al.
Publicado: (2020)

Nutritional Ergogenic Aids in Combat Sports: A Systematic Review and Meta-Analysis
por: Vicente-Salar, Néstor, et al.
Publicado: (2022)

Characterization of Non‐Motor Fluctuations Using the Movement Disorder Society Non‐Motor Rating Scale
por: van Wamelen, Daniel Johannes, et al.
Publicado: (2022)

Parkinson’s Disease: Personalized Pathway of Care for Device-Aided Therapies (DAT) and the Role of Continuous Objective Monitoring (COM) Using Wearable Sensors
por: Metta, Vinod, et al.
Publicado: (2021)

Parkinson Symptoms and Health Related Quality of Life as Predictors of Costs: A Longitudinal Observational Study with Linear Mixed Model Analysis
por: Martinez-Martín, Pablo, et al.
Publicado: (2015)

A Novel Boot Camp Program to Help Guide Personalized Exercise in People with Parkinson Disease
por: Domingos, Josefa, et al.
Publicado: (2021)

A Consensus Set of Outcomes for Parkinson’s Disease from the International Consortium for Health Outcomes Measurement
por: de Roos, Paul, et al.
Publicado: (2017)

The Role of Parkinson Nurses for Personalizing Care in Parkinson’s Disease: A Systematic Review and Meta-Analysis
por: van Munster, Marlena, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_g9kt0ego0fi62verm7phk48k4g